New guidelines for the treatment of tuberculosis

Publisher： Elsevier

ISSN： 1473-3099

Source： The Lancet Infectious Diseases, Vol.3, Iss.5, 2003-05, pp. : 265-265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Relevance of New Drug Combinations for Modern Tuberculosis Treatment - A Patent Perspective

Recent Patents on Anti-Infective Drug Discovery, Vol. 8, Iss. 2, 2013-08 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

New Agents for the Treatment of Tuberculosis on Clinical Study Phases II/III

Current Respiratory Medicine Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 101-106

Bentham Science Publishers

Access to resources Recommend Favorite

Nano-carriers for the Treatment of Tuberculosis

Recent Patents on Anti-Infective Drug Discovery, Vol. 12, Iss. 2, 2018-05 ,pp. : 95-106

Bentham Science Publishers

Access to resources Recommend Favorite

The 1999 WHO-ISH Guidelines for the Management of Hypertension - New targets, new treatment and a comprehensive approach to total cardiovascular risk reduction

By HANSSON LENNART HEDNER THOMAS HIMMELMANN ANDERS

Blood Pressure, Vol. 8, Iss. 1, 1999-04 ,pp. : 3-5

Informa Healthcare

Access to resources Recommend Favorite

New Chemotherapy and Immunotherapy for Tuberculosis

Current Respiratory Medicine Reviews, Vol. 10, Iss. 2, 2014-06 ,pp. : 74-87

Bentham Science Publishers

Access to resources Recommend Favorite